Category: Clinical Trials

A woman and a man sit facing each other, both with their hands raised towards a bright, glowing light between them. Large, ethereal hands hover above, enhancing the glow. A small plant is visible to the side. The scene suggests healing or connection.

EMDR Is Still Dubious

A recent meta-analysis of eye movement desensitization and reprocessing (EMDR) therapy concludes that the evidence “confirms” EMDR is effective in treating depression. It is a great example of the limitations of meta-analysis, and how easy it is to create essentially a false narrative using poor quality research. EMDR was “developed” by Dr. Francine Shapiro in 1987. It is the notion that bilateral...

/ October 23, 2024
Close-up of a hand performing acupuncture, carefully inserting thin needles into a person's skin. The background is softly blurred, emphasizing the focus on the acupuncture practice.

Latest Acupuncture Pseudoscience

JAMA Internal Medicine just published an article titled: Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk, A Randomized Clinical Trial. In an accompanying editorial comment, Jerard Z. Kneifati-Hayek and Mitchell H. Katz write: “This was a methodologically rigorous study; there were multiple experienced acupuncturists, the comparison group used a well thought-out sham control, and patients were followed up for 1...

/ October 16, 2024
Donald Trump

Donald Trump bragged that “right-to-try” has saved thousands of lives. It hasn’t.

Former President Donald Trump bragged in his acceptance speech at the Republican National Convention that "right-to-try" had saved "thousands of lives"? What's the real story? (Hint: Nowhere near that.)

/ July 22, 2024

FDA Advisory Committee Recommends approval of new Alzheimer’s drug Donanemab

If approved, donanemab would be the third FDA approved disease-modifying beta-amyloid treatment for Alzheimer’s disease.

/ June 23, 2024
Prescription Drugs

Generic Drugs: Are they different?

Standards in place for generic drugs should give consumers confidence that these products are just as effective as their brand-name equivalent.

/ May 23, 2024
EDTA structure. Chelation

We finally learn from TACT2 what we should have known two decades ago: Chelation therapy doesn’t work for heart disease

At SBM, we've long argued that chelation therapy for heart disease is quackery. An abstract presented recently finally confirmed that. Why did it take so long?

/ April 29, 2024
Turbo cancer?

COVID-19 vaccine-caused “turbo cancer” nonsense just keeps getting more turbocharged

No matter how implausible it is or how weak the evidence for it is, the myth that COVID vaccines cause "turbo cancer" just won't die. Quite the contrary, alas. Antivaxxers are—dare I say?—turbocharging it with bad science.

/ April 22, 2024

Fenbendazole is fast becoming the laetrile of the 2020s

Antivaxxers who "repurposed" deworming drugs like ivermectin and fenbendazole are peddling cancer "miracle cure" testimonials that remind me of laetrile and Stanislaw Burzynski. Truly, everything old is new again.

/ March 4, 2024

Adios Aduhelm

The controversial and never-proven-effective drug to treat Alzheimer's disease, aducanumab (Aduhelm) has been discontinued.

/ February 15, 2024
Macular degeneration

Pegcetacoplan (Syfovre™) for macular degeneration: an update

SBM's guest contributor and ophthalmologist, Dr. David Weinberg, provides an update on the phase 3 trials of pegcetacoplan for macular degeneration. The results are still disappointing.

/ January 11, 2024